Pembrolizumab vs Chemotherapy in Advanced Esophageal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
J. Clin. Oncol 2020 Oct 07;[EPub Ahead of Print], T Kojima, MA Shah, K Muro, E Francois, A Adenis, CH Hsu, T Doi, T Moriwaki, SB Kim, SH Lee, J Bennouna, K Kato, L Shen, P Enzinger, SK Qin, P Ferreira, J Chen, G Girotto, C de la Fouchardiere, H Senellart, R Al-Rajabi, F Lordick, R Wang, S Suryawanshi, P Bhagia, SP Kang, JP MetgesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.